Jun 30, 2026 07:30AM
Jun 12, 2026 04:05PM
Jun 8, 2026 04:05PM
Jun 8, 2026 04:05PM
May 27, 2026 04:05PM
May 12, 2026 04:05PM
May 11, 2026 04:05PM Savara Announces Participation in the H.C. Wainwright & Co. 4th Annual BioConnect Investor Conference
Apr 17, 2026 04:05PM
Apr 15, 2026 04:05PM
Apr 15, 2026 04:05PM
Apr 7, 2026 08:08AM
Apr 7, 2026 08:05AM
Mar 31, 2026 04:27AM
Mar 30, 2026 08:05AM Savara receives EMA validation for MOLBREEVI application in rare lung disease
Mar 30, 2026 08:05AM
Mar 16, 2026 11:22AM
Mar 13, 2026 08:06AM
Mar 13, 2026 08:05AM
Mar 6, 2026 04:05PM
Mar 6, 2026 04:05PM
Mar 4, 2026 04:05PM Savara Announces Participation in 2026 Citizens Life Sciences Conference
Feb 23, 2026 04:58AM
Feb 20, 2026 04:15PM
Feb 20, 2026 04:15PM
Feb 13, 2026 04:05PM
Feb 4, 2026 04:05PM
Jan 27, 2026 08:06AM
Jan 27, 2026 08:05AM Savara Announces Amendment to Hercules Capital Debt Facility Providing up to $75M of Additional Debt Funding Upon U.S. Food and Drug Administration (FDA) Approval of MOLBREEVI*
Jan 16, 2026 04:05PM
Jan 8, 2026 04:05PM
Dec 23, 2025 06:46AM
Dec 22, 2025 08:31AM
Dec 22, 2025 08:30AM
Dec 17, 2025 08:05AM
Dec 11, 2025 08:05AM Savara receives European patent intent for MOLBREEVI formulation
Dec 11, 2025 08:05AM
Dec 2, 2025 08:06AM
Dec 2, 2025 08:05AM
Nov 20, 2025 04:05PM
Nov 12, 2025 04:05PM
Nov 3, 2025 04:05PM
Oct 31, 2025 04:05PM Savara closes $149.5M public offering with full underwriter option
Oct 31, 2025 04:05PM
Oct 29, 2025 09:43PM
Oct 29, 2025 09:43PM
Oct 29, 2025 04:07PM
Oct 29, 2025 04:07PM
Oct 29, 2025 04:01PM
Oct 29, 2025 04:01PM Savara announces $75M Royalty Funding Agreement with RTW to Support the Potential Launch of MOLBREEVI* in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP)
Oct 17, 2025 08:05AM

324,694 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All